Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Employment agrmnt Quarterly results Auditor change Appointed director Director comp. Acq. announced
|
BioCardia, Inc. (BCDA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/14/2023 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Granted 4,500 shares
@ $0.884, valued at
$4k
|
|
06/02/2023 |
4
| GILLIS EDWARD M (Senior Vice President, Devices) has filed a Form 4 on BioCardia, Inc.
Txns:
| Paid exercise price by delivering 15,512 shares
@ $1.77, valued at
$27.5k
|
|
06/02/2023 |
4
| McClung David (CFO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Paid exercise price by delivering 20,676 shares
@ $1.77, valued at
$36.6k
|
|
06/02/2023 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Paid exercise price by delivering 36,821 shares
@ $1.77, valued at
$65.2k
|
|
05/30/2023 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 6,200 shares
@ $1.6, valued at
$9.9k
|
|
05/22/2023 |
4
| GILLIS EDWARD M (Senior Vice President, Devices) has filed a Form 4 on BioCardia, Inc.
Txns:
| Granted 40,490 shares
@ $1.7, valued at
$68.8k
Granted 43,803 options to buy
@ $1.7, valued at
$74.5k
|
|
05/22/2023 |
4
| McClung David (CFO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Granted 61,389 shares
@ $1.7, valued at
$104.4k
Granted 68,265 options to buy
@ $1.7, valued at
$116.1k
|
|
05/22/2023 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Granted 109,324 shares
@ $1.7, valued at
$185.9k
Granted 159,723 options to buy
@ $1.7, valued at
$271.5k
|
|
05/12/2023 |
4
| ZSEBO KRISZTINA M (Director) has filed a Form 4 on BioCardia, Inc.
Txns:
| Granted 31,085 options to buy
@ $1.49, valued at
$46.3k
|
|
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2022 |
4
| FROST PHILLIP MD ET AL (10% Owner) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 595,238 shares
@ $1.68, valued at
$1000k
|
|
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 3,100 shares
@ $1.87, valued at
$5.8k
Bought 1,400 shares
@ $1.86, valued at
$2.6k
|
|
10/11/2022 |
4
| McClung David (CFO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 2,000 shares
@ $2.07, valued at
$4.1k
|
|
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 3,100 shares
@ $1.81, valued at
$5.6k
Bought 1,400 shares
@ $1.87, valued at
$2.6k
|
|
09/22/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 2,750 shares
@ $1.92, valued at
$5.3k
|
|
06/13/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 4,500 shares
@ $1.46, valued at
$6.6k
|
|
05/18/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Paid exercise price by delivering 31,446 shares
@ $1.32, valued at
$41.5k
|
|
05/18/2022 |
4
| GILLIS EDWARD M (Senior Vice President, Devices) has filed a Form 4 on BioCardia, Inc.
Txns:
| Paid exercise price by delivering 12,358 shares
@ $1.32, valued at
$16.3k
|
|
05/18/2022 |
4
| McClung David (CFO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Paid exercise price by delivering 20,632 shares
@ $1.32, valued at
$27.2k
|
|
05/13/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 1,000 shares
@ $1.3, valued at
$1.3k
Bought 11,302 shares
@ $1.2, valued at
$13.6k
Bought 2,698 shares
@ $1.38, valued at
$3.7k
|
|
05/02/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Bought 2,300 shares
@ $1.59, valued at
$3.7k
Bought 2,700 shares
@ $1.61, valued at
$4.3k
|
|
04/18/2022 |
4
| Altman Peter (President and CEO) has filed a Form 4 on BioCardia, Inc.
Txns:
| Granted 76,734 shares
@ $0 Bought 13,500 shares
@ $1.3852, valued at
$18.7k
Granted 141,000 options to buy
@ $1.49, valued at
$210.1k
|
|
|
|
|